Vascular Endothelial Growth Factor-A (VEGF-A) Mediates Activin A-Induced Human Trophoblast Endothelial-Like Tube Formation

作者: Yan Li , Hua Zhu , Christian Klausen , Bo Peng , Peter C. K. Leung

DOI: 10.1210/EN.2015-1228

关键词:

摘要: Remodeling of maternal spiral arteries during pregnancy requires a subpopulation extravillous cytotrophoblasts (EVTs) to differentiate into endovascular EVTs. Activin A, which is abundantly expressed at the maternal-fetal interface, has been shown promote trophoblast invasion, but its role in differentiation remains unknown. Vascular endothelial growth factor-A (VEGF-A) well recognized as key regulator differentiation. Whether and how activin A might regulate VEGF-A production human trophoblasts relationship have yet be determined. In present study, we found that increased primary immortalized (HTR8/SVneo) EVT cells. addition, enhanced HTR8/SVneo endothelial-like tube formation, these effects were attenuated by pretreatment with small interfering RNA targeting or VEGF receptor 1/2 inhibitor SU4312. Pretreatment activin/TGF-β typ...

参考文章(47)
Zhi-Ying He, Hung-Ching Liu, Carol A. Mele, Larry Barmat, Lucinda L. Veeck, Owen Davis, Zev Rosenwaks, Expression of inhibin/activin subunits and their receptors and binding proteins in human preimplantation embryos. Journal of Assisted Reproduction and Genetics. ,vol. 16, pp. 73- 80 ,(1999) , 10.1023/A:1022564722353
Hendrik Gille, Joe Kowalski, Bing Li, Jennifer LeCouter, Barbara Moffat, Thomas F Zioncheck, Nicolas Pelletier, Napoleone Ferrara, None, Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific vascular endothelial growth factor mutants. Journal of Biological Chemistry. ,vol. 276, pp. 3222- 3230 ,(2001) , 10.1074/JBC.M002016200
JIANPING QU, KARL THOMAS, Inhibin and Activin Production in Human Placenta Endocrine Reviews. ,vol. 16, pp. 485- 507 ,(1995) , 10.1210/EDRV-16-4-485
Fiona Lyall, Ian A. Greer, Fiona Boswell, Richard Fleming, Suppression of serum vascular endothelial growth factor immunoreactivity in normal pregnancy and in pre-eclampsia. British Journal of Obstetrics and Gynaecology. ,vol. 104, pp. 223- 228 ,(1997) , 10.1111/J.1471-0528.1997.TB11050.X
Paulomi B. Aldo, Graciela Krikun, Irene Visintin, Charles Lockwood, Roberto Romero, Gil Mor, A novel three-dimensional in vitro system to study trophoblast-endothelium cell interactions. American Journal of Reproductive Immunology. ,vol. 58, pp. 98- 110 ,(2007) , 10.1111/J.1600-0897.2007.00493.X
Christopher W Redman, Ian L Sargent, Latest advances in understanding preeclampsia. Science. ,vol. 308, pp. 1592- 1594 ,(2005) , 10.1126/SCIENCE.1111726
Napoleone Ferrara, Terri Davis-Smyth, THE BIOLOGY OF VASCULAR ENDOTHELIAL GROWTH FACTOR Endocrine Reviews. ,vol. 18, pp. 4- 25 ,(1997) , 10.1210/EDRV.18.1.0287
Aernout Luttun, Peter Carmeliet, Soluble VEGF receptor Flt1: the elusive preeclampsia factor discovered? Journal of Clinical Investigation. ,vol. 111, pp. 600- 602 ,(2003) , 10.1172/JCI18015
C Bearfield, E Jauniaux, N Groome, I L Sargent, S Muttukrishna, The secretion and effect of inhibin A, activin A and follistatin on first-trimester trophoblasts in vitro. European Journal of Endocrinology. ,vol. 152, pp. 909- 916 ,(2005) , 10.1530/EJE.1.01928
J. C. Cooper, A. M. Sharkey, J. McLaren, D. S. Charnock-Jones, S. K. Smith, Localization of vascular endothelial growth factor and its receptor, flt, in human placenta and decidua by immunohistochemistry Reproduction. ,vol. 105, pp. 205- 213 ,(1995) , 10.1530/JRF.0.1050205